Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

eMed vs Vytora Health

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

6.8

eMed

Best for Employees whose company offers eMed GLP-1 benefits and wants at-home labs
★★★☆☆3.4
BrandedSemaglutideTirzepatideAt-Home Labs
Visit eMed
8.7

Vytora Health

Best for compounded or brand-name GLP-1 with named pharmacy partners, 50 states
★★★★4.4

Starting at $150/mo

CompoundedBrandZepboundMounjaro
Visit Vytora Health

Side-by-Side Comparison

FeatureeMedVytora Health
Overall Score6.8/108.7/10
Starting Price$150/mo
Editorial Rating3.4 ★ /54.4 ★ /5
Features8 features8 features
States Available051
Compounded✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

eMed

Pros

  • Prescribes FDA-approved branded GLP-1s (semaglutide and tirzepatide)
  • At-home blood collection makes lab work convenient
  • Clinician review and ongoing side-effect plus adherence support
  • Works with CVS Caremark so eligible employees can buy through benefits
  • Established digital health company with national scale

Cons

  • Distributed mainly via employers, with limited direct cash-pay access
  • No public transparent monthly price for individuals
  • Eligibility and subsidy depend on what the employer chooses to cover
  • Best suited to workforces, not casual self-pay shoppers

Vytora Health

Pros

  • All 50 states plus DC, with per-state video-vs-audio compliance disclosed
  • Both compounded and brand-name options on one platform — uncommon
  • LegitScript Approved and HIPAA compliant
  • Pharmacy partners named publicly: Vials Pharmacy (TX) and Greenwich Biosciences
  • Operating entity disclosed: Wasef Health, PC (Pinellas Park, FL)
  • Competitive monthly pricing ($180 sema / $249 tirz) plus a 3-month bundle saving 17%
  • Brand-name Mounjaro and Zepbound available at $1,399/mo for FDA-approved options

Cons

  • Brand-name Mounjaro/Zepbound at $1,399/mo is near retail — insured patients may do better via LillyDirect Self Pay ($449-$699/mo)
  • Compounded tirzepatide at $249/mo is mid-market, above the $149-199 floor
  • Dose tiers aren't broken out — 'all doses included' means low-dose patients pay the same as high-dose
  • Initial consultation cost not shown on the public pricing page
  • Limited per-prescriber state licensure detail

Our Verdict

Winner: Vytora HealthScore: 8.7/10

Vytora Health edges out eMed with a higher overall score of 8.7/10 and is particularly strong for compounded or brand-name GLP-1 with named pharmacy partners, 50 states. eMed remains a solid alternative, especially if you're looking for Employees whose company offers eMed GLP-1 benefits and wants at-home labs.

Glossary references

Key terms in this article, linked to their canonical definitions.

Related comparisons

Continue exploring eMed and Vytora Health head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.